MedTrace Logo

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

NCT01741974 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2012-12-06

No results posted yet for this study

Summary

The purpose of this study is to investigate the anti-atherosclerotic and anti-climacteric action of natural drug Karinat based on phytoestrogen-rich botanicals in perimenopausal women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Karinat

DRUG

Placebo

Sugar pill manufactured to mimic Karinat 500 mg tablet

Sponsors & Collaborators

  • Institute for Atherosclerosis Research, Russia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2012-06-30
Completion
2012-10-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741974 on ClinicalTrials.gov